Detalles de la búsqueda
1.
A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer.
Clin Breast Cancer
; 22(1): 32-42, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34158245
2.
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).
Breast Cancer Res Treat
; 119(2): 391-8, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19851858
3.
Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: subgroup analyses of a phase 3 study.
Breast Cancer Res Treat
; 118(1): 81-7, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19308727
4.
Dose-dense anthracycline-based chemotherapy for node-positive breast cancer.
J Clin Oncol
; 20(17): 3637-43, 2002 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12202664
5.
Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What's Old Is New.
Clin Breast Cancer
; 15(5): e277-85, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26025883
6.
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.
J Nucl Med
; 43(4): 500-9, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11937594
7.
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.
J Nucl Med
; 44(11): 1806-14, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14602864
8.
[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.
Nucl Med Biol
; 29(7): 719-27, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12381452
9.
Myalgias and arthralgias associated with paclitaxel.
Oncology (Williston Park)
; 17(2): 271-7; discussion 281-2, 286-8, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12632867
10.
HER-2 testing in breast cancer using parallel tissue-based methods.
JAMA
; 291(16): 1972-7, 2004 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-15113815
11.
Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab.
Clin Med Insights Oncol
; 6: 287-303, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22933844
12.
Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0012.
J Clin Oncol
; 29(8): 1014-21, 2011 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21220618
13.
PET tumor metabolism in locally advanced breast cancer patients undergoing neoadjuvant chemotherapy: value of static versus kinetic measures of fluorodeoxyglucose uptake.
Clin Cancer Res
; 17(8): 2400-9, 2011 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21364034
14.
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.
Clin Cancer Res
; 17(14): 4799-805, 2011 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21750198
15.
The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors.
J Natl Compr Canc Netw
; 7 Suppl 7: S1-29; quiz S30, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19878635
16.
Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.
J Clin Oncol
; 26(30): 4875-82, 2008 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18725648
17.
Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.
J Clin Oncol
; 26(27): 4449-57, 2008 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18626006
18.
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
Breast Cancer Res Treat
; 105(1): 87-94, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17268819
19.
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.
J Clin Oncol
; 24(18): 2793-9, 2006 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16682724
20.
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.
Cancer
; 103(4): 680-8, 2005 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15637688